Evidence map›Paper›PMID 38673899›Full record

ArticleInternational journal of molecular sciences2024

The Dopaminergic Cells in the Median Raphe Region Regulate Social Behavior in Male Mice.

Tiago Chaves, Bibiána Török, Csilla Lea Fazekas, Pedro Correia, Eszter Sipos, Dorottya Várkonyi, Zsuzsanna E Tóth, Fanni Dóra, Árpád Dobolyi, Dóra Zelena

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. The Role of Dopamine Neurotransmitters in Neurological Diseases: New Sight.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Tiago ChavesInstitute of Physiology, Medical School, Centre for Neuroscience, Szentágothai Research Centre, University of Pécs, H7624 Pécs, Hungary.
Bibiána TörökInstitute of Physiology, Medical School, Centre for Neuroscience, Szentágothai Research Centre, University of Pécs, H7624 Pécs, Hungary.
Csilla Lea FazekasInstitute of Physiology, Medical School, Centre for Neuroscience, Szentágothai Research Centre, University of Pécs, H7624 Pécs, Hungary.
Pedro CorreiaInstitute of Physiology, Medical School, Centre for Neuroscience, Szentágothai Research Centre, University of Pécs, H7624 Pécs, Hungary.
Eszter SiposLaboratory of Behavioral and Stress Studies, Institute of Experimental Medicine, H1083 Budapest, Hungary.
Dorottya VárkonyiInstitute of Physiology, Medical School, Centre for Neuroscience, Szentágothai Research Centre, University of Pécs, H7624 Pécs, Hungary.
Zsuzsanna E TóthLaboratory of Neuroendocrinology and in Situ Hybridization, Department of Anatomy, Histology and Embryology, Semmelweis University, H1094 Budapest, Hungary.
Fanni DóraHuman Brain Tissue Bank, Laboratory of Neuromorphology, Department of Anatomy, Histology and Embryology, Semmelweis University, H1094 Budapest, Hungary.
Árpád DobolyiLaboratory of Molecular and Systems Neurobiology, Department of Physiology and Neurobiology, Eötvös Loránd University, H1117 Budapest, Hungary.ORCID 0000-0003-0397-2991
Dóra ZelenaInstitute of Physiology, Medical School, Centre for Neuroscience, Szentágothai Research Centre, University of Pécs, H7624 Pécs, Hungary.ORCID 0000-0001-5616-1100
Semmelweis University · HUHUN-REN Institute of Experimental Medicine · HUEötvös Loránd University · HU

Funding

National Brain Research Program of the Hungarian Academy of Sciences NAP 3.0National Research Development and Innovation Office of Hungary K141934, K138763, K134221 and K120311Thematic Excellence Program 2021 Health Sub-program of the Ministry for Innovation and Tech-nology in Hungary TKP2021-EGA-16 project of the Pécs University as well as TKP2021-EGA-25 project of the Sem-melweis University
6 · The paper itself

Abstract

According to previous studies, the median raphe region (MRR) is known to contribute significantly to social behavior. Besides serotonin, there have also been reports of a small population of dopaminergic neurons in this region. Dopamine is linked to reward and locomotion, but very little is known about its role in the MRR. To address that, we first confirmed the presence of dopaminergic cells in the MRR of mice (immunohistochemistry, RT-PCR), and then also in humans (RT-PCR) using healthy donor samples to prove translational relevance. Next, we used chemogenetic technology in mice containing the Cre enzyme under the promoter of the dopamine transporter. With the help of an adeno-associated virus, designer receptors exclusively activated by designer drugs (DREADDs) were expressed in the dopaminergic cells of the MRR to manipulate their activity. Four weeks later, we performed an extensive behavioral characterization 30 min after the injection of the artificial ligand (Clozapine-N-Oxide). Stimulation of the dopaminergic cells in the MRR decreased social interest without influencing aggression and with an increase in social discrimination. Additionally, inhibition of the same cells increased the friendly social behavior during social interaction test. No behavioral changes were detected in anxiety, memory or locomotion. All in all, dopaminergic cells were present in both the mouse and human samples from the MRR, and the manipulation of the dopaminergic neurons in the MRR elicited a specific social response.

Indexed as

Dopaminergic NeuronsSocial BehaviorAnimalsBehavior, AnimalClozapineDopamineHumansMaleMiceMice, Inbred C57BLRaphe NucleiClozapineclozapine N-oxideDopaminebehaviordopamineDREADDmedian raphe region

Identifiers

PMID38673899
PMCPMC11050709
OpenAlexW4394821605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.